Brief: ABIONYX Pharma End-December Cash And Cash Equivalents Of 9.2 Million Euros

Abionyx Pharma SA

04/02/2021 17:36

Feb 4 (Reuters) - ABIONYX Pharma SA  ABNX.PA :
    * ABIONYX PHARMA PROVIDES AN UPDATE ON ITS CASH POSITION AND
THE
START OF ITS CLINICAL ACTIVITIES IN Q4 2020
    * CASH AND CASH EQUIVALENTS OF EUR 9.2 MILLION AS OF
DECEMBER 31,
2020
    * POSITIVE THERAPEUTIC SIGNALS FOUND IN ATUN IN FRANCE AND
ITALY
FOR ULTRA-RARE KIDNEY DISEASE
    * POSITIVE PRECLINICAL RESULTS PUBLISHED IN JOURNAL
METABOLISM
DEMONSTRATING THAT CER-001 IMPROVES RENAL FUNCTION
    * COMPANY HAS NOT GENERATED ANY REVENUES FOR YEAR 2020
    * COMPANY IS AWAITING FURTHER PRECLINICAL AND CLINICAL
RESULTS

Source text for Eikon:  ID:nBw4XXgFwa 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))